Supplements for Lipid Lowering: What Does the Evidence Show?

被引:4
|
作者
Mirzai, Saeid [1 ]
Laffin, Luke J. J. [2 ]
机构
[1] Cleveland Clin Fdn, Dept Internal Med, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Cardiovasc Med, Sect Prevent Cardiol & Rehabil, 9500 Euclid Ave,Mail Code JB1, Cleveland, OH 44195 USA
关键词
Cardiovascular disease; Hyperlipidemia; Cholesterol; Dietary supplements; Food and Drug Administration; Statins; RED YEAST RICE; DIETARY-SUPPLEMENTS; LDL-CHOLESTEROL; GREEN TEA; CLINICAL-TRIAL; PLANT STEROLS; RISK-FACTORS; METAANALYSIS; CONSUMPTION; ABSORPTION;
D O I
10.1007/s11886-023-01903-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeIn this review, the regulation, proposed hypolipidemic mechanism, and efficacy of common dietary supplements (DSs) marketed for cardiovascular health are discussed.Recent FindingsData demonstrate modest but inconsistent lipid-lowering effects with common DSs such as probiotics, soluble fibers, plant sterols, green tea, berberine, guggul, niacin, and garlic. Furthermore, data is limited regarding turmeric, hawthorn, and cinnamon. Red yeast rice has shown to be a beneficial DS, but its safety and efficacy are dependent upon its production quality and monacolin K content, respectively. Finally, soy proteins and omega-3 fatty acid-rich foods can have significant health benefits if used to displace other animal products as part of a healthier diet.Despite the rising use of DSs, data demonstrate unpredictable results. Patients should be educated on the difference between these DSs and evidence-based lipid-lowering medications proven to improve cardiovascular outcomes.
引用
收藏
页码:795 / 805
页数:11
相关论文
共 50 条
  • [21] A historical, evidence-based, and narrative review on commonly used dietary supplements in lipid-lowering
    Grant, Jelani K.
    Dangl, Michael
    Ndumele, Chiadi E.
    Michos, Erin D.
    Martin, Seth S.
    [J]. JOURNAL OF LIPID RESEARCH, 2024, 65 (02)
  • [22] Lipid lowering: what and when to monitor
    Criqui, Michael H.
    Golomb, Beatrice A.
    [J]. LANCET, 2008, 372 (9638): : 516 - 517
  • [23] What does Griselda show
    Papi, Maria Francesca
    [J]. RASSEGNA DELLA LETTERATURA ITALIANA, 2011, 115 (01): : 186 - 186
  • [24] Diabetes, Incretin Therapy and Thoracic Aortic Aneurysm - What Does the Evidence Show?
    Krizhanovskii, Camilla
    Franco-Cereceda, Anders
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (05) : 432 - 439
  • [25] What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults
    F. Andrasik
    [J]. Neurological Sciences, 2007, 28 : S70 - S77
  • [26] AID AND GROWTH: WHAT DOES THE CROSS-COUNTRY EVIDENCE REALLY SHOW?
    Rajan, Raghuram G.
    Subramanian, Arvind
    [J]. REVIEW OF ECONOMICS AND STATISTICS, 2008, 90 (04) : 643 - 665
  • [27] PPI and antiplatelet Co-therapy: What does the current evidence show?
    Moayyedi, Paul
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 34 - 34
  • [28] Statins' still controversial role in pulmonary fibrosis: What does the evidence show?
    Andreikos, Dimitrios
    Karampitsakos, Theodoros
    Tzouvelekis, Argyrios
    Stratakos, Grigoris
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 77
  • [29] COPD What evidence does the Urine Results show on the Risks of Lung Cancer?
    Klein, Friederike
    [J]. PNEUMOLOGIE, 2015, 69 (04): : 190 - 190
  • [30] Oxygen Supplementation in COPD Exacerbation with Hypoxia and Hypercapnia: What Does the Evidence Show?
    Saha, Biplab K.
    Bonnier, Alyssa
    Chong, Woon H.
    [J]. SOUTHERN MEDICAL JOURNAL, 2021, 114 (09) : 620 - 622